Abstract | BACKGROUND: OBJECTIVES: We wished to test the hypotheses that hemostatic function is altered in subjects with AF who develop dementia, and that long-term warfarin anticoagulation is protective against this complication. PATIENTS AND METHODS: RESULTS: Of the 218 subjects assessed, 145 (66%) were prescribed warfarin. Forty-nine (22%) met TICSm/IQCODE criteria for dementia. D-dimer, F1+2 and TAT levels were higher in AF subjects with dementia compared with those without (medians 81 vs. 60 ng mL(-1), P = 0.008; 0.76 vs. 0.49 nmol L(-1), P = 0.006; and 1.78 vs. 1.44 microg L(-1), P = 0.003, respectively). These associations became of borderline statistical significance following adjustment for age. Logistic regression showed a trend towards warfarin use being independently associated with reduced prevalence of dementia (odds ratio 0.52, P = 0.08). CONCLUSIONS: We found evidence of increased thrombin generation and fibrin turnover in subjects with AF and dementia compared with those without dementia. Long-term warfarin use may be protective against the development of dementia in subjects with AF.
|
Authors | M Barber, R C Tait, J Scott, A Rumley, G D O Lowe, D J Stott |
Journal | Journal of thrombosis and haemostasis : JTH
(J Thromb Haemost)
Vol. 2
Issue 11
Pg. 1873-8
(Nov 2004)
ISSN: 1538-7933 [Print] England |
PMID | 15550013
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticoagulants
- Biomarkers
|
Topics |
- Aged
- Aged, 80 and over
- Anticoagulants
(pharmacology, therapeutic use)
- Atrial Fibrillation
(blood, complications, drug therapy)
- Biomarkers
(blood)
- Cohort Studies
- Dementia
(blood, etiology, prevention & control)
- Drug Evaluation
- Female
- Follow-Up Studies
- Hemostasis
(drug effects, physiology)
- Humans
- Logistic Models
- Male
- Predictive Value of Tests
- Prevalence
- Surveys and Questionnaires
|